Clinical trial

Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)

NCT06959784

StatusENROLLING_BY_INVITATION

Study typeINTERVENTIONAL

Start date2024-01-01

PhasePHASE4

Study timeline

Study start (actual)2024-01-01Date precision: day

Registry last updated2025-05-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitusunresolved

Cardiovascular Diseasesunresolved

Cerebrovascular Diseaseunresolved

Interventions

semaglutideDRUG · verified · RxNorm: semaglutide

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

China-Japan Friendship Hospitallead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06959784 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.